Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase
Giles, F J, Kantarjian, H M, le Coutre, P D, Baccarani, M, Mahon, F-X, Blakesley, R E, Gallagher, N J, Gillis, K, Goldberg, S L, Larson, R A, Hochhaus, A, Ottmann, O GVolume:
26
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2011.355
Date:
May, 2012
File:
PDF, 368 KB
english, 2012